🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Blood Samples for the Study of Peanut, Tree Nut and Other Food Allergies

Recruitingn/aAges 1 Year - 75 YearsAllUniversity of Colorado, Denver
NCT02192866 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Food allergies are now a major problem. These experiments involve getting blood from people with food allergies and from people without food allergies. The blood collected will be used to answer questions and find information about peanut and other food allergies. Samples will come from: * People signed up by the investigators at the University of Colorado Denver * University of North Carolina, Massachusetts General Hospital, Children's Hospital of Colorado and the Immune Tolerance Network (Benaroya Research Institute) where people have been treated for peanut allergies * University of North Carolina, Massachusetts General Hospital, National Jewish Health and The Children's Hospital in Denver where people have taken part or will take part in clinically indicated oral food challenges. Blood and health histories from the University of North Carolina, Massachusetts General Hospital, Nati

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: This protocol is to draw blood for a variety of related studies of food allergy. For this reason, we will list each group of subjects and the inclusion criteria for that group. 1. De-identified sera or plasma from patients who have undergone Oral ImmunoTherapy (OIT) for peanut allergy. These samples already exist. * Inclusion criteria: 1. patients have been enrolled in a controlled trial of OIT for peanuts, and had at least one oral challenge. 2. Age 1-75. 2. De-identified samples from patients who are undergoing clinically indicated food challenges for peanut allergy. * Inclusion criteria: 1. concern regarding possible allergy to peanuts, 2. age 1-75, 3. plan to undergo a clinically indicated challenge with peanuts. 3. Patients with peanut allergy. * Inclusion criteria: 1. excellent history of a systemic reaction to peanuts, 2. age 6-75. 4. Patients with other food allergies (especially tree nuts). * Inclusion criteria: 1. excellent history of a systemic reaction to tree nuts or other foods, 2. age 6-75. 5. Normal controls. * Inclusion criteria: 1. no known food allergies, 2. recent ingestion of peanuts without difficulty, and 3. age 6-75. Exclusion Criteria: 1. Any known significant medical or psychiatric diagnosis 2. Use of an investigational drug within 30 days 3. Use of omalizumab (anti-IgE; Xolair) within 6 months
💊

What it tests

  • Not listed
📍

Where

1 site
University of Colorado School of Medicine
Denver, United States
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy